![](https://www.Immune-System-Research.com/"wp-content/uploads"/2020/12/SYN1143-is-a-Selective-Dual-Inhibitor-of-c-Met-RON-2020-12-12.jpg)
Receptor d’origin nantais (RON) is a receptor tyrosine kinase (RTK), which is usually expressed at a low level in epithelial…
![](https://www.Immune-System-Research.com/"wp-content/uploads"/2020/08/BIIB068-is-a-Selective-Reversible-and-Orally-Active-BTK-Inhibitor-2020-08-25.jpg)
In this article, we will introduce a selective, reversible, and orally active BTK inhibitor, BIIB068. As a selective inhibitor, BIIB068…
![](https://www.Immune-System-Research.com/"wp-content/uploads"/2019/11/Remibrutinib-is-an-Orally-Active-BTK-Inhibitor-for-the-Chronic-Urticaria-Treatment-2019-11-09.jpg)
Chronic urticaria is a heterogeneous, persistent, and severely debilitating disease. Bruton’s tyrosine kinase (BTK) is a non-receptor kinase that plays…
![](https://www.Immune-System-Research.com/"wp-content/uploads"/2019/08/Evobrutinib-is-an-Orally-Active-BTK-Inhibitor-for-Immunological-Diseases-Treatment-2019-08-15.jpg)
Bruton’s tyrosine kinase (BTK), a member of the Tec family of tyrosine kinases, is expressed in B cells, macrophages, and…
![](https://www.Immune-System-Research.com/"wp-content/uploads"/2019/07/G-744-is-an-Orally-Active-Btk-Inhibitor-to-Treat-Arthritis-2019-07-18.jpg)
A study from Xiaojing Wang discovered and identified a novel Btk inhibitor G-744 that has potential to treat arthritis. Bruton’s…